financetom
Business
financetom
/
Business
/
Alignment Healthcare Insider Sold Shares Worth $1,050,236, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Alignment Healthcare Insider Sold Shares Worth $1,050,236, According to a Recent SEC Filing
Jul 22, 2024 12:28 AM

03:12 AM EDT, 07/22/2024 (MT Newswires) -- Robert Thomas Freeman, Chief Financial Officer, on July 17, 2024, sold 105,000 shares in Alignment Healthcare ( ALHC ) for $1,050,236. Following the Form 4 filing with the SEC, Freeman has control over a total of 1,279,836 shares of the company, with 865,407 shares held directly and 414,429 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1832466/000162828024032361/xslF345X03/wk-form4_1721434921.xml

Price: 9.91, Change: -0.16, Percent Change: -1.59

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Leap Therapeutics Shares Drop After Discontinuing Phase 3 Studies of Gastric Cancer Treatment
Leap Therapeutics Shares Drop After Discontinuing Phase 3 Studies of Gastric Cancer Treatment
Jan 28, 2025
03:42 PM EST, 01/28/2025 (MT Newswires) -- Leap Therapeutics ( LPTX ) dropped 71% Tuesday after saying it will not move forward with phase 3 studies of sirexatamab for treatment of gastric cancer after initial data from part C of the ongoing study. The trial evaluating sirexatamab in combination with tislelizumab and chemotherapy to treat gastroesophageal junction and gastric cancer...
Why Is Silexion Therapeutics Stock Soaring Over 100% On Tuesday?
Why Is Silexion Therapeutics Stock Soaring Over 100% On Tuesday?
Jan 28, 2025
On Tuesday, Silexion Therapeutics Corp. ( SLXN ) released new preclinical data for SIL-204, its next-generation siRNA therapeutic candidate. SIL-204, administered in an extended-release formulation, reduced tumor growth by ~50% after 30 days, with ~50% of tumors showing complete necrosis in human pancreatic tumors harboring a G12D mutation xenografted into mice. SIL-204 administered subcutaneously inhibited tumor growth in mouse metastatic pancreatic...
NFE's Mexico LNG plant producing above capacity, company says
NFE's Mexico LNG plant producing above capacity, company says
Jan 28, 2025
HOUSTON, Jan 28 (Reuters) - A floating liquefied natural gas (LNG) plant operated by U.S. energy firm New Fortress Energy ( NFE ) off Mexico's coast is producing at 20% above its capacity, and the company has shipped nine cargoes from the facility since August, it said on Tuesday. NFE has been struggling to secure LNG for its power-generation operations...
Commerce Bancshares Insider Sold Shares Worth $1,724,352, According to a Recent SEC Filing
Commerce Bancshares Insider Sold Shares Worth $1,724,352, According to a Recent SEC Filing
Jan 28, 2025
03:37 PM EST, 01/28/2025 (MT Newswires) -- Kevin G Barth, Executive Vice President, on January 24, 2025, sold 26,092 shares in Commerce Bancshares ( CBSH ) for $1,724,352. Following the Form 4 filing with the SEC, Barth has control over a total of 127,654 shares of the company, with 44,289 shares held directly and 83,365 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/22356/000112760225002082/xslF345X05/form4.xml...
Copyright 2023-2026 - www.financetom.com All Rights Reserved